Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan/Rosuvastatin Combination in Hypertension and Dyslipidemia
NCT02166814Phase 3Completed
- Sponsor
- Boryung
- Start
- Aug 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fimasartan, rosuvastatin in essential hypertension, dyslipidemia, sponsored by Boryung. Started Aug 2014; status: completed.
02
Drugs
fimasartanrosuvastatin
03
Conditions
essential hypertensiondyslipidemia
Beyond the preview
Go deeper on NCT02166814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02166814.